Composition
- Active ingredients
- ERDAFITINIB
Official product information
Drugs@FDA lists the approved labels, letters and reviews for application ANDA218578.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Brand name
- Erdafitinib
- Dosage form
- Tablet
- Applicant
- Natco Pharma LTD
- Status
- Tentative approval
- FDA approval
- 2 Feb 2026
- Application
- ANDA218578-001